Prognostic Value of Adipokine Levels of Patients With Chronic Heart Failure

NCT02812797 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2020-03-04

No results posted yet for this study

Summary

The purpose of this study is to determine whether expressions of adipokines can provide prognostic information concerning patients with chronic heart failure.

Conditions

Sponsors & Collaborators

  • Chongqing Medical University

    lead OTHER

Principal Investigators

  • Dongying Zhang, doctor · Chongqing Medical University

Eligibility

Min Age
12 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2019-08-31
Completion
2020-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02812797 on ClinicalTrials.gov